Immunome Inc.

IMNM chart

Immunome Inc. news

• Will New Desmoid Tumor Data Change Immunome (IMNM) Stock Narrative

  Simply Wall Street · Oct 27, 10:26 AM EDT

• Immunome stock price target maintained at $40 by H.C. Wainwright

  Investing.com · Oct 27, 9:02 AM EDT

• Immunome presents additional varegacestat trial data at ESMO By Investing.com

  Investing.com Canada · Oct 26, 7:24 AM EDT

• Immunome presents additional clinical data for varegacestat at ESMO 2026

  TipRanks · Oct 26, 7:10 AM EDT

• Immunome Presents Additional Clinical Data for Varegacestat in Desmoid Tumors at ESMO 2026

  Yahoo Finance · Oct 26, 7:00 AM EDT

• Understanding Momentum Shifts in (IMNM)

  Stock Traders Daily · Oct 22, 7:26 PM EDT

• Immunome, Inc. (IMNM) stock price, news, quote and history

  Yahoo Finance Australia · Oct 22, 2:44 AM EDT

• William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage

  Yahoo Finance · Oct 21, 12:30 PM EDT

• Immunome (IMNM) Following FDA Clearance Is Its Oncology Story Back In Value Focus

  Yahoo Finance · Oct 13, 6:16 PM EDT

• Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  Yahoo Finance · Oct 6, 4:02 PM EDT

• Immunome (IMNM) Is Down 6.5% After FDA Clears IND For Novel ADC IM-1340 Trial – Has The Bull Case Changed?

  Yahoo Finance · Oct 2, 9:10 AM EDT

• Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues

  Yahoo Finance · Oct 1, 5:11 AM EDT

Immunome Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-10-05
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-06-12
• 10-Q10-Q2026-05-12
• 8-K8-K2026-05-12
• DEF 14ADEF 14A2026-04-24
• 10-K10-K2026-03-03
• 8-K8-K2026-03-03
• 8-K8-K2025-12-17
• 8-K8-K2025-12-15
• 10-Q10-Q2025-11-06

About Immunome Inc.

Ticker

IMNM (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Bothell, WA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1472012

Frequently asked questions